Jens Juul Holst

Jens Juul Holst

Professor


  1. Published

    Isolation and molecular characterization of porcine calcitonin gene-related peptide (CGRP) and its endocrine effects in the porcine pancreas. / Rasmussen, T N; Bersani, M; Schmidt, P; Thim, L; Kofod, Hans; Jørgensen, P N; Poulsen, S S; Holst, J J.

    In: Pancreas, Vol. 16, No. 2, 03.1998, p. 195-204.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in Type 2 diabetic patients. / Seifarth, C.; Bergmann, Jesper; Holst, J.J.; Ritzel, R.; Schmiegel, W.; Nauck, M.A.

    In: Diabet. Med., No. 15, 1998, p. 485-491.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    The ethanol augmentation of glucose-induced insulin secretion is abolished by calcium antagonism with nifedipine: No evidence for a role of glucagon-like peptide-1 (GLP-1). / Svartberg, J.; Holst, J.J.; Gutniak, M.K.; Adner, N.

    In: Pancreas, No. 16, 1998, p. 66-71.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. / Toft-Nielsen, M; Madsbad, Sten; Holst, Jens Juul.

    In: Diabetologia, Vol. 41, No. 10, 1998, p. 1180-1186.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Glucagon-like peptide-1 retards gastric emptying and small bowel transit in the rat: Effect mediated through central or enteric nervous mechanisms. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: Dig. Dis. Sci., No. 43, 1998, p. 2284-2290.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin. / Tolessa, T.; Gutniak, M.K.; Holst, J.J.; Efendic, S.; Hellstrom, P.M.

    In: J. Clin. Invest., No. 102, 1998, p. 764-774.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    The inhibitory effect of glucagon-like peptide-1 (7-36) amide on antral motility is antagonized by its N-terminally truncated primary metabolite GLP-1 (9-36) amide. / Wettergren, A.; Wojdemann, M.; Holst, J.J.

    In: Peptides, No. 19, 1998, p. 877-882.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outflow. / Wettergren, A.; Wojdemann, M.; Holst, J.J.

    In: Am. J. Physiol., No. 275, 1998, p. G984-G992.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans. / Wettergren, A.; Pridal, L.; Wöjdemann, M.; Holst, J.J.

    In: Regul. Pept., No. 77, 1998, p. 83-88.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Overnight GLP-1 normalizes fasting but not daytime plasma glucose levels in NIDDM patients. / Willms, B.; Idowu, K.; Holst, J.J.; Creutzfeldt, W.; Nauck, M.A.

    In: Exp. Clin. Endocrinol. Diabetes, No. 106, 1998, p. 103-107.

    Research output: Contribution to journalJournal articleResearchpeer-review

ID: 4207